Research: Solvay Pharmaceuticals, Inc.

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

Pharmaceutical Business Review

2009-09-09 12:04
Solvay Biologicals Completes Validation For Its Cell-Based Production Facility
Also announces registration of trivalent adjuvant cell-based seasonal influenza vaccine Grippol Neo in Russia

2009-06-15 12:03
Socma Announces Five New Members In Second Quarter
New SOCMA members, Raindance Technologies, Solvay Fluorides, Pharmacore, IEM and Siemens Building Technologies

2009-09-28 12:00
Abbott's Solvay Deal: Don't Get Too Excited
The $6.6 billion purchase is about financial engineering, not acquiring new drugs.